ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

559 hedge funds and large institutions have $26B invested in Alexion Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 72 funds opening new positions, 254 increasing their positions, 178 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
559
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
19
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$675M
Puts
$459M
Net Calls
Net Calls Change

Top Buyers

1 +$430M
2 +$394M
3 +$245M
4
BlackRock
BlackRock
New York
+$158M
5
TP
Third Point
New York
+$152M

Top Sellers

1 -$1.09B
2 -$685M
3 -$303M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$224M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$214M
Name Holding Trade Value Shares
Change
Change in
Stake
476
$134K
477
$131K
478
$130K
479
$112K
480
$111K
481
$111K
482
$97K
483
$82K
484
$79K
485
$73K
486
$72K
487
$70K
488
$70K
489
$61K
490
$60.8K
491
$59K
492
$56K
493
$55K
494
$53K
495
$49K
496
$49K
497
$48.7K
498
$48K
499
$47K
500
$44K